The Therapeutic Goods Administration has approved the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia.
The Australian manufacture of COVID-19 Vaccine AstraZeneca, established by
Read More
Diverse COVID-19 vaccine portfolio needed, says Australian Greens
The Australian Greens have called on the federal government to increase the production of COVID-19 vaccines.
The party recently welcomed the news that AstraZeneca has been approved by the Therapeutic Goods
Read More
Read More
$1bn agreement between fed government and Seqirus for new vaccine manufacturing facility in Melbourne
A new high-tech vaccine manufacturing facility will be developed in Melbourne to secure Australia’s long-term supply of critical health products including pandemic influenza vaccines and life-saving
Read More
Read More
CSL signs agreement with Australian Government for UQ vaccine supply
Biotech company CSL Limited will supply the Australian Government with 51 million doses of The University of Queensland’s COVID-19 vaccine candidate if it proves successful, under a heads of agreement
Read More
Read More
UQ vaccine scientists report positive results from pre-clinical testing
Pre-clinical testing of The University of Queensland’s COVID-19 vaccine has produced positive indications about its potential effectiveness and ability to be manufactured.
Project co-leader associate
Read More
Read More
CSL consortium to make plasma against coronavirus
Australian biotech giant CSL has formed a consortium with Takeda Pharmaceutical Company to develop a potential plasma therapy to fight coronavirus.
The alliance, which also brings together leading biomedical
Read More
Read More
Siemens expands APS Industrial distribution partnership into New Zealand
A new strategic partnership between Siemens and Cuthbert Stewart Limited (CSL) will see more manufacturing products sold in New Zealand through the APS master distributor.
Siemens’ factory automation,
Read More
Read More
Australia’s top 100 manufacturers for 2020 revealed
Caltex Australia has topped the list of Australia’s leading manufacturers for 2020 for the second consecutive year, with this year’s ‘Top 100’ reflective of Australia’s investments in advanced
Read More
Read More
CSL to acquire majority stake in Chinese manufacturer Ruide
CSL has announced that it has agreed to acquire 80 per cent equity of plasma-derived therapies manufacturer Wuhan Zhong Yuan Rui De Biological Products (“Ruide”) from Humanwell Healthcare Group (“Humanwell”)
Read More
Read More
CSL to continue expansion plans despite China slowdown
Melbourne-based biotech manufacturer CSL says the slowing of China’s economy will not affect its Asian expansion plans.
Read More
Read More
New blood at CSL
Pharmaceutical giant CSL will farewell its CEO Brian McNamee who has been one of Australia’s longest-serving chief executives.
Read More
Read More
CSL consider moving manufacturing offshore
A combination of ongoing industrial relations issues and a strong Aussie dollar have prompted healthcare manufacturer CSL to consider moving manufacturing operations offshore.
Read More
Read More
CSL lifts 2013 profit expectations
Pharmaceutical manufacturer CSL today revised their US Dollar profit outlook for 2013 up.
Read More
Read More
CSL discusses Broadmeadows site developments
The first of CSL’s new buildings from a $250 million investment at its Broadmeadows site will start producing biopharmaceuticals for clinical trials early next year.
Read More
Read More
CSL doubles manufacturing capacity
CSL Biotherapies, a subsidiary of CSL Limited Australia and one of the world’s leading manufacturers of influenza vaccine, has announced it has been awarded a contract by the United States Department of Health Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile.
Read More
Read More
Pharmaceuticals are the future
Australian Pharmaceutical manufacturing looks set for substantial growth to meet the increasing demand of Asian health-care products.
Read More
Read More